Evaluating lipid levels in heart attack patients at the Montreal Heart Institute
Timing of Lipid Testing During Hospitalization for MI and Subsequent Management of Dyslipidemia An Observational Study to Reduce the Care Gaps in Dyslipidemia in Canada
This study is testing how reliable cholesterol tests are for heart attack patients during their hospital stay to see if the timing of these tests can help doctors make better treatment decisions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Montreal Heart Institute Academic / other |
| Locations | 2 sites (Montreal, Quebec and 1 other locations) |
| Trial ID | NCT06388668 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the reliability of lipid measurements, specifically LDL, non-HDL, and apoB values, during hospitalization for myocardial infarction. Patients admitted to the Cardiac Care Unit will undergo non-fasting lipid panel testing on the day of admission and again on day 2. The study will compare lipid levels at these two time points and again 4-6 weeks post-discharge to determine how timing affects treatment decisions for dyslipidemia. The goal is to understand the best timing for lipid testing to optimize patient care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are hospitalized for myocardial infarction.
Not a fit: Patients who are not hospitalized for myocardial infarction or those who do not consent to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for dyslipidemia in heart attack patients.
How similar studies have performed: While this approach is exploratory, similar studies have indicated that timing of lipid testing can influence treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients ≥18 years old * Hospitalized at the Cardiac Care Unit for Myocardial Infarction (either NSTEMI or STEMI) * Lipid panel performed on day 0 of admission * Willing to provide informed consent Exclusion Criteria: * None
Where this trial is running
Montreal, Quebec and 1 other locations
- Montreal Heart Institute — Montreal, Quebec, Canada (Not_yet_recruiting)
- Montreal Heart Institute — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Guillaume Marquis-Gravel, MD, MSc — Montreal Heart Institute
- Study coordinator: Suzy Otis
- Email: suzy.otis@icm-mhi.org
- Phone: (514) 376-3330
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.